UNICREDIT BANK/CALL/ABBVIE/150/0.1/17.12.25 Share Price

Warrant

DE000HD1H6F1

Market Closed - Börse Stuttgart 10:17:40 03/07/2024 pm IST
2.51 EUR -5.99% Intraday chart for UNICREDIT BANK/CALL/ABBVIE/150/0.1/17.12.25
Current month-13.45%
1 month+11.06%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
03/24/03 2.51 -5.99%
02/24/02 2.67 -8.87%
01/24/01 2.93 +1.03%
28/24/28 2.9 +1.75%
27/24/27 2.85 -7.77%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 10:17 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD1H6F
ISINDE000HD1H6F1
Date issued 28/12/2023
Strike 150 $
Maturity 17/12/2025 (532 Days)
Parity 10 : 1
Emission price 2.02
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.93
Lowest since issue 1.89
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.092
Difference Strike -13.84 $
Difference Strike %-9.23%
Theoretical value 2.515
Implied Volatility 25.53 %
Total Loss Probability 42.49 %
Intrinsic value 1.283
Present value 1.232
Break even 177.13 €
Theta-0.01x
Vega0.06x
Rho0.1x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
163.8 USD
Average target price
183.2 USD
Spread / Average Target
+11.84%
Consensus